Our website uses cookies to enable essential features and improve your browsing experience. Additionally, cookies enhance overall website functionality and user experience. By choosing I Accept, you agree to our use of non-essential cookies and other tracking technologies.

You have the ability to manage your settings or withdraw your consent at any time. We are committed to maintaining the privacy and security of your personal information. For detailed information on how we use cookies, including how to manage your privacy and preferences, please visit our cookie policy .
Developmentaid logo
Register
Print
Print
Abon Biopharm (Hangzhou) Co. Ltd

Abon Biopharm (Hangzhou) Co. Ltd

General
Jobs • 0
Shortlists/Awards • 1
Pricing strategy • 0
Partners/Competitors • 5
Last update: Dec 6, 2024 Last update: Dec 6, 2024
General
Jobs
Shortlists/Awards
Pricing strategy
Partners/Competitors

Details

Legal residence:China
Organization type:Consulting organization
Funding agencies:WB
 World Bank HQ
Sectors:Health, Laboratory & Measurement, Procurement
 Health, Laboratory & Measurement, Procurement
Sanctions:Check now
Status:
Active

Attachments • 0

About

ABON is mainly engaged in research and development of IVD products with a registered capital of $22 million. ABON has been registered with the U. S. FDA as a medical device establishment and obtained Euro CE certification. Our leading products include women’s health, infectious disease, drugs of abuse, oncology, cardiovascular and respiratory. There are now very good commanding market shares in the United States, Canada, Europe, Israel, Australia, New Zealand, and Japan. And from 2011, ABON started to enter China domestic market.

Awards

Top partners

Top competitors

Want to unlock full information?
Register with us or sign in to access the organization database.
Learn more about our membership benefits